Please complete the fields below:
Advances in modern intensive chemotherapy, and identifying different levels of risk, have revolutionised the treatment of children with leukaemia. But resistant leukaemia subtypes and late effects of chemotherapy and relapses remain significant problems, and leukaemia still causes 30% of cancer deaths in children. We particularly need new, targeted treatments for treating children who have relapsed following earlier treatment. Those with ...